Key issues in Alzheimer's disease inflammation - PubMed (original) (raw)
Key issues in Alzheimer's disease inflammation
NR Cooper et al. Neurobiol Aging. 2000.
No abstract available
Similar articles
- An update on the interactions between Alzheimer's disease, autophagy and inflammation.
Bostancıklıoğlu M. Bostancıklıoğlu M. Gene. 2019 Jul 15;705:157-166. doi: 10.1016/j.gene.2019.04.040. Epub 2019 Apr 25. Gene. 2019. PMID: 31029603 Review. - Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Gauthier S, et al. Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8. Prog Neurobiol. 2013. PMID: 23578568 Review. - The Role of Mast Cells in Alzheimer's Disease.
Shaik-Dasthagirisaheb YB, Conti P. Shaik-Dasthagirisaheb YB, et al. Adv Clin Exp Med. 2016 Jul-Aug;25(4):781-7. doi: 10.17219/acem/61914. Adv Clin Exp Med. 2016. PMID: 27629855 Review. - Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].
Swedish Council on Health Technology Assessment. Swedish Council on Health Technology Assessment. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review. - Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
Liu C, Cui G, Zhu M, Kang X, Guo H. Liu C, et al. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8342-55. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674199 Free PMC article. Review.
Cited by
- Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.
Monsonego A, Zota V, Karni A, Krieger JI, Bar-Or A, Bitan G, Budson AE, Sperling R, Selkoe DJ, Weiner HL. Monsonego A, et al. J Clin Invest. 2003 Aug;112(3):415-22. doi: 10.1172/JCI18104. J Clin Invest. 2003. PMID: 12897209 Free PMC article. - Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease.
Pattison LR, Kotter MR, Fraga D, Bonelli RM. Pattison LR, et al. J Neurol. 2006 Sep;253(9):1137-42. doi: 10.1007/s00415-006-0198-8. Epub 2006 Sep 22. J Neurol. 2006. PMID: 16998646 Review. - Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.
Shie FS, Nivison M, Hsu PC, Montine TJ. Shie FS, et al. Curr Med Chem. 2009;16(6):643-51. doi: 10.2174/092986709787458399. Curr Med Chem. 2009. PMID: 19199928 Free PMC article. Review. - Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
Monsonego A, Maron R, Zota V, Selkoe DJ, Weiner HL. Monsonego A, et al. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10273-8. doi: 10.1073/pnas.191118298. Epub 2001 Aug 21. Proc Natl Acad Sci U S A. 2001. PMID: 11517335 Free PMC article. - TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.
Tobinick E, Gross H, Weinberger A, Cohen H. Tobinick E, et al. MedGenMed. 2006 Apr 26;8(2):25. MedGenMed. 2006. PMID: 16926764 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources